NCT02975934 · BASELINE
Baseline characteristics
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- denoms
- counts
- group Id
- BG000
- value
- 270
- group Id
- BG001
- value
- 135
- group Id
- BG002
- value
- 405
- units
- Participants
- groups
- description
- Oral rucaparib (monotherapy). Rucaparib: Rucaparib will be administered daily.
- id
- BG000
- title
- Rucaparib
- description
- Oral abiraterone acetate (monotherapy, given in combination with prednisone). Oral enzalutamide (monotherapy). Intravenous docetaxel (monotherapy, given in combination with prednisone or prednisolone). Abiraterone acetate or Enzalutamide or Docetaxel: Abiraterone acetate and enzalutamide will be administered daily. Docetaxel will be administered every 3 weeks.
- id
- BG001
- title
- Abiraterone Acetate or Enzalutamide or Docetaxel
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- <=18 years
- measurements
- group Id
- BG000
- value
- 84
- group Id
- BG001
- value
- 32
- group Id
- BG002
- value
- 116
- title
- Between 18 and 65 years
- measurements
- group Id
- BG000
- value
- 186
- group Id
- BG001
- value
- 103
- group Id
- BG002
- value
- 289
- title
- >=65 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Categorical
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 45
- upper Limit
- 90
- value
- 70
- group Id
- BG001
- lower Limit
- 47
- upper Limit
- 92
- value
- 71
- group Id
- BG002
- lower Limit
- 45
- upper Limit
- 92
- value
- 70
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Female
- measurements
- group Id
- BG000
- value
- 270
- group Id
- BG001
- value
- 135
- group Id
- BG002
- value
- 405
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 7
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 216
- group Id
- BG001
- value
- 103
- group Id
- BG002
- value
- 319
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 51
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 79
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 5
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 10
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 14
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 199
- group Id
- BG001
- value
- 103
- group Id
- BG002
- value
- 302
- title
- White
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 3
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 53
- group Id
- BG001
- value
- 27
- group Id
- BG002
- value
- 80
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 111
- group Id
- BG001
- value
- 56
- group Id
- BG002
- value
- 167
- title
- North America
- categories
- measurements
- group Id
- BG000
- value
- 141
- group Id
- BG001
- value
- 73
- group Id
- BG002
- value
- 214
- title
- Europe
- categories
- measurements
- group Id
- BG000
- value
- 10
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 13
- title
- Australia
- categories
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 11
- title
- Israel
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 132
- group Id
- BG001
- value
- 68
- group Id
- BG002
- value
- 200
- title
- 0
- measurements
- group Id
- BG000
- value
- 138
- group Id
- BG001
- value
- 67
- group Id
- BG002
- value
- 205
- title
- 1
- description
- Measure Description: Eastern Cooperative Oncology Group (ECOG) Performance Status Scale. ECOG 0 = Fully active, able to carry on all pre-disease performance without restriction. ECOG 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (eg, light house work or office work)
- param Type
- COUNT_OF_PARTICIPANTS
- title
- ECOG Performance Status (at stratification)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 29
- group Id
- BG001
- value
- 15
- group Id
- BG002
- value
- 44
- title
- BRCA1
- measurements
- group Id
- BG000
- value
- 172
- group Id
- BG001
- value
- 86
- group Id
- BG002
- value
- 258
- title
- BRCA2
- measurements
- group Id
- BG000
- value
- 69
- group Id
- BG001
- value
- 34
- group Id
- BG002
- value
- 103
- title
- ATM
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Gene Alteration (at stratification)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 0.1
- upper Limit
- 1247
- value
- 26.9
- group Id
- BG001
- lower Limit
- 0
- upper Limit
- 1039
- value
- 28.8
- group Id
- BG002
- lower Limit
- 0
- upper Limit
- 1247
- value
- 27.8
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Baseline prostate specific antigen (PSA)
- unit Of Measure
- ng/ml
- classes
- categories
- measurements
- group Id
- BG000
- value
- 173
- group Id
- BG001
- value
- 96
- group Id
- BG002
- value
- 269
- description
- The scale for the Gleason score ranges from 2 to 10, with higher scores indicating a worse prognosis
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Gleason score ≥8 at diagnosis
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 106
- group Id
- BG001
- value
- 55
- group Id
- BG002
- value
- 161
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Measurable Disease per Independent Radiological Review (IRR)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 235
- group Id
- BG001
- value
- 114
- group Id
- BG002
- value
- 349
- title
- Bone
- categories
- measurements
- group Id
- BG000
- value
- 118
- group Id
- BG001
- value
- 60
- group Id
- BG002
- value
- 178
- title
- Nodal
- categories
- measurements
- group Id
- BG000
- value
- 74
- group Id
- BG001
- value
- 46
- group Id
- BG002
- value
- 120
- title
- Visceral
- description
- Participants may be counted in more than one category
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Metastases site(s) by IRR
- unit Of Measure
- Participants
- population Description
- Intent-to-Treat (ITT) Population included all randomized participants (participants with breast cancer gene \[BRCA\] mutated metastatic castration-resistant prostate cancer \[mCRPC\] and participants with ataxia- telangiectasia mutated serine/threonine kinase \[ATM\] mutated mCRPC).
Complete source fields
- denoms
- counts
- group Id
- BG000
- value
- 270
- group Id
- BG001
- value
- 135
- group Id
- BG002
- value
- 405
- units
- Participants
- groups
- description
- Oral rucaparib (monotherapy). Rucaparib: Rucaparib will be administered daily.
- id
- BG000
- title
- Rucaparib
- description
- Oral abiraterone acetate (monotherapy, given in combination with prednisone). Oral enzalutamide (monotherapy). Intravenous docetaxel (monotherapy, given in combination with prednisone or prednisolone). Abiraterone acetate or Enzalutamide or Docetaxel: Abiraterone acetate and enzalutamide will be administered daily. Docetaxel will be administered every 3 weeks.
- id
- BG001
- title
- Abiraterone Acetate or Enzalutamide or Docetaxel
- description
- Total of all reporting groups
- id
- BG002
- title
- Total
- measures
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- <=18 years
- measurements
- group Id
- BG000
- value
- 84
- group Id
- BG001
- value
- 32
- group Id
- BG002
- value
- 116
- title
- Between 18 and 65 years
- measurements
- group Id
- BG000
- value
- 186
- group Id
- BG001
- value
- 103
- group Id
- BG002
- value
- 289
- title
- >=65 years
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Age, Categorical
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 45
- upper Limit
- 90
- value
- 70
- group Id
- BG001
- lower Limit
- 47
- upper Limit
- 92
- value
- 71
- group Id
- BG002
- lower Limit
- 45
- upper Limit
- 92
- value
- 70
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Age, Continuous
- unit Of Measure
- years
- classes
- categories
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Female
- measurements
- group Id
- BG000
- value
- 270
- group Id
- BG001
- value
- 135
- group Id
- BG002
- value
- 405
- title
- Male
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Sex: Female, Male
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 7
- title
- Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 216
- group Id
- BG001
- value
- 103
- group Id
- BG002
- value
- 319
- title
- Not Hispanic or Latino
- measurements
- group Id
- BG000
- value
- 51
- group Id
- BG001
- value
- 28
- group Id
- BG002
- value
- 79
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Ethnicity (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 1
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 1
- title
- American Indian or Alaska Native
- measurements
- group Id
- BG000
- value
- 4
- group Id
- BG001
- value
- 1
- group Id
- BG002
- value
- 5
- title
- Asian
- measurements
- group Id
- BG000
- value
- 0
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 0
- title
- Native Hawaiian or Other Pacific Islander
- measurements
- group Id
- BG000
- value
- 10
- group Id
- BG001
- value
- 4
- group Id
- BG002
- value
- 14
- title
- Black or African American
- measurements
- group Id
- BG000
- value
- 199
- group Id
- BG001
- value
- 103
- group Id
- BG002
- value
- 302
- title
- White
- measurements
- group Id
- BG000
- value
- 3
- group Id
- BG001
- value
- 0
- group Id
- BG002
- value
- 3
- title
- More than one race
- measurements
- group Id
- BG000
- value
- 53
- group Id
- BG001
- value
- 27
- group Id
- BG002
- value
- 80
- title
- Unknown or Not Reported
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Race (NIH/OMB)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 111
- group Id
- BG001
- value
- 56
- group Id
- BG002
- value
- 167
- title
- North America
- categories
- measurements
- group Id
- BG000
- value
- 141
- group Id
- BG001
- value
- 73
- group Id
- BG002
- value
- 214
- title
- Europe
- categories
- measurements
- group Id
- BG000
- value
- 10
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 13
- title
- Australia
- categories
- measurements
- group Id
- BG000
- value
- 8
- group Id
- BG001
- value
- 3
- group Id
- BG002
- value
- 11
- title
- Israel
- param Type
- NUMBER
- title
- Region of Enrollment
- unit Of Measure
- participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 132
- group Id
- BG001
- value
- 68
- group Id
- BG002
- value
- 200
- title
- 0
- measurements
- group Id
- BG000
- value
- 138
- group Id
- BG001
- value
- 67
- group Id
- BG002
- value
- 205
- title
- 1
- description
- Measure Description: Eastern Cooperative Oncology Group (ECOG) Performance Status Scale. ECOG 0 = Fully active, able to carry on all pre-disease performance without restriction. ECOG 1 = Restricted in physically strenuous activity but ambulatory and able to carry out work of a light or sedentary nature (eg, light house work or office work)
- param Type
- COUNT_OF_PARTICIPANTS
- title
- ECOG Performance Status (at stratification)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 29
- group Id
- BG001
- value
- 15
- group Id
- BG002
- value
- 44
- title
- BRCA1
- measurements
- group Id
- BG000
- value
- 172
- group Id
- BG001
- value
- 86
- group Id
- BG002
- value
- 258
- title
- BRCA2
- measurements
- group Id
- BG000
- value
- 69
- group Id
- BG001
- value
- 34
- group Id
- BG002
- value
- 103
- title
- ATM
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Gene Alteration (at stratification)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- lower Limit
- 0.1
- upper Limit
- 1247
- value
- 26.9
- group Id
- BG001
- lower Limit
- 0
- upper Limit
- 1039
- value
- 28.8
- group Id
- BG002
- lower Limit
- 0
- upper Limit
- 1247
- value
- 27.8
- dispersion Type
- FULL_RANGE
- param Type
- MEDIAN
- title
- Baseline prostate specific antigen (PSA)
- unit Of Measure
- ng/ml
- classes
- categories
- measurements
- group Id
- BG000
- value
- 173
- group Id
- BG001
- value
- 96
- group Id
- BG002
- value
- 269
- description
- The scale for the Gleason score ranges from 2 to 10, with higher scores indicating a worse prognosis
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Gleason score ≥8 at diagnosis
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 106
- group Id
- BG001
- value
- 55
- group Id
- BG002
- value
- 161
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Measurable Disease per Independent Radiological Review (IRR)
- unit Of Measure
- Participants
- classes
- categories
- measurements
- group Id
- BG000
- value
- 235
- group Id
- BG001
- value
- 114
- group Id
- BG002
- value
- 349
- title
- Bone
- categories
- measurements
- group Id
- BG000
- value
- 118
- group Id
- BG001
- value
- 60
- group Id
- BG002
- value
- 178
- title
- Nodal
- categories
- measurements
- group Id
- BG000
- value
- 74
- group Id
- BG001
- value
- 46
- group Id
- BG002
- value
- 120
- title
- Visceral
- description
- Participants may be counted in more than one category
- param Type
- COUNT_OF_PARTICIPANTS
- title
- Metastases site(s) by IRR
- unit Of Measure
- Participants
- population Description
- Intent-to-Treat (ITT) Population included all randomized participants (participants with breast cancer gene \[BRCA\] mutated metastatic castration-resistant prostate cancer \[mCRPC\] and participants with ataxia- telangiectasia mutated serine/threonine kinase \[ATM\] mutated mCRPC).
Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0
Preserved source evidence · Not medical advice
Triangle